Terms: = Brain cancer AND EPS15, AF-1P, 2060, ENSG00000085832, P42566, MLLT5, AF1P
41 results:
1. Invasive Giant Prolactinoma.
Alkhaibary A; Alharbi A; Khairy S
World Neurosurg; 2024 Jan; 181():21-22. PubMed ID: 37827431
[TBL] [Abstract] [Full Text] [Related]
2. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract] [Full Text] [Related]
3. EHD1 promotes the cancer stem cell (CSC)-like traits of glioma cells via interacting with CD44 and suppressing CD44 degradation.
Lu Y; Wang W; Tan S
Environ Toxicol; 2022 Sep; 37(9):2259-2268. PubMed ID: 35616188
[TBL] [Abstract] [Full Text] [Related]
4. Long-Term Time Series Forecasting and Updates on Survival Analysis of Glioblastoma Multiforme: A 1975-2018 Population-Based Study.
Alexopoulos G; Zhang J; Karampelas I; Patel M; Kemp J; Coppens J; Mattei TA; Mercier P
Neuroepidemiology; 2022; 56(2):75-89. PubMed ID: 35172317
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale - a bicentric retrospective study.
Barz M; Gerhardt J; Bette S; Aftahy AK; Huber T; Combs SE; Ryang YM; Wiestler B; Skardelly M; Gepfner-Tuma I; Behling F; Schmidt-Graf F; Meyer B; Gempt J
BMC Neurol; 2021 Nov; 21(1):446. PubMed ID: 34781889
[TBL] [Abstract] [Full Text] [Related]
6. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
[TBL] [Abstract] [Full Text] [Related]
7. 1‑Palmitoyl‑2‑linoleoyl‑3‑acetyl‑rac‑glycerol ameliorates EGF‑induced MMP‑9 expression by promoting receptor desensitization in MDA‑MB‑231 cells.
Yang KH; Kim GT; Choi S; Yoon SY; Kim JW
Oncol Rep; 2020 Jul; 44(1):241-251. PubMed ID: 32377695
[TBL] [Abstract] [Full Text] [Related]
8. Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.
Dho SE; Silva-Gagliardi N; Morgese F; Coyaud E; Lamoureux E; Berry DM; Raught B; McGlade CJ
Sci Rep; 2019 Aug; 9(1):12471. PubMed ID: 31462741
[TBL] [Abstract] [Full Text] [Related]
9. Modulated Electrohyperthermia in Integrative cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study.
Fiorentini G; Sarti D; Milandri C; Dentico P; Mambrini A; Fiorentini C; Mattioli G; Casadei V; Guadagni S
Integr Cancer Ther; 2019; 18():1534735418812691. PubMed ID: 30580645
[TBL] [Abstract] [Full Text] [Related]
10. Association between acromegaly and a single nucleotide polymorphism (rs2854744) in the IGFBP3 gene.
Gao M; Zhu B; Xu Z; Liu S; Liu J; Zhang G; Gao Y; Fan Y; Kang X
BMC Med Genet; 2018 Oct; 19(1):182. PubMed ID: 30290787
[TBL] [Abstract] [Full Text] [Related]
11. Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors.
Harada K; Igaki H; Abe E; Ariga T; Hayashi N; Kanemoto A; Komiyama T; Matsumoto Y; Nakano T; Onimaru R; Saito H; Sumi M; Tago M; Tanaka K; Maebayashi K; Aoyama H;
Int J Clin Oncol; 2018 Dec; 23(6):1015-1022. PubMed ID: 29971621
[TBL] [Abstract] [Full Text] [Related]
12. Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery.
Rowlands MA; Mondesire-Crump I; Levin A; Mauguen A; Francis JH; Dunkel IJ; Brodie SE; Gobin YP; Abramson DH
PLoS One; 2018; 13(4):e0195395. PubMed ID: 29698399
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of 30-2 Standard and Fast programs of Swedish Interactive Threshold Algorithm of Humphrey Field Analyzer for perimetry in patients with intracranial tumors.
Singh MD; Jain K
Indian J Ophthalmol; 2017 Nov; 65(11):1198-1202. PubMed ID: 29133651
[TBL] [Abstract] [Full Text] [Related]
14. Hypermutations in gliomas: a potential immunotherapy target.
Finocchiaro G; Langella T; Corbetta C; Pellegatta S
Discov Med; 2017 Feb; 23(125):113-120. PubMed ID: 28371614
[TBL] [Abstract] [Full Text] [Related]
15. Spatio-temporal regulation of EGFR signaling by the eps15 homology domain-containing protein 3 (EHD3).
Amessou M; Ebrahim AS; Dilly A; Joseph M; Tabolina M; Chukkapalli S; Meroueh L; Syed JT; Liddane A; Lang SL; Al-Katib A; Kandouz M
Oncotarget; 2016 Nov; 7(48):79203-79216. PubMed ID: 27811356
[TBL] [Abstract] [Full Text] [Related]
16. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract] [Full Text] [Related]
17. Neurophysiological intraoperative monitoring during an optic nerve schwannoma removal.
San-Juan D; Escanio Cortés M; Tena-Suck M; Orozco Garduño AJ; López Pizano JA; Villanueva Domínguez J; Fernández Gónzalez-Aragón M; Gómez-Amador JL
J Clin Monit Comput; 2017 Oct; 31(5):1059-1064. PubMed ID: 27586244
[TBL] [Abstract] [Full Text] [Related]
18. Brief descriptive epidemiology of primary malignant brain tumors from North-East India.
Krishnatreya M; Kataki AC; Sharma JD; Bhattacharyya M; Nandy P; Hazarika M
Asian Pac J Cancer Prev; 2014; 15(22):9871-3. PubMed ID: 25520120
[TBL] [Abstract] [Full Text] [Related]
19. Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.
Jung TY; Lee JY; Kim DS; Park HJ; Kim CY; Ra YS; Lee MJ; Kim SH; Baek HJ; Kim IH; Park KD; Kim SK
J Neurooncol; 2015 Jan; 121(2):413-9. PubMed ID: 25366367
[TBL] [Abstract] [Full Text] [Related]
20. Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma.
Schmainda KM; Prah M; Connelly J; Rand SD; Hoffman RG; Mueller W; Malkin MG
Neuro Oncol; 2014 Jun; 16(6):880-8. PubMed ID: 24431219
[TBL] [Abstract] [Full Text] [Related]
[Next]
